Skip to content

H.R. 1628 · 118th Congress (2023–2025)

CBD Product Safety and Standardization Act of 2023

This bill requires the Food and Drug Administration (FDA) to regulate food containing cannabidiol (CBD) derived from hemp as a food additive. (The FDA has determined that food containing added CBD cannot be sold in interstate commerce.)

Under this bill, in order to be sold, a food containing CBD derived from hemp must conform with current FDA requirements pertaining to food additives or be generally recognized as safe (GRAS). (Under current law, a food additive with the GRAS designation is not subject to FDA premarket review and approval requirements.)

In addition, such a food must comply with all other relevant FDA and labeling requirements.

Such a food shall be exempt from an existing provision that prohibits the sale of a food containing an additive that is (1) an FDA-approved drug or biological product, or (2) subject to certain clinical investigations.

The FDA must issue regulations pertaining to such foods that specify (1) the maximum amount of CBD derived from hemp per serving, (2) labeling and packaging requirements, and (3) any conditions for intended use.

Show official title

To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 1628’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. H. Morgan Griffith (R-VA-9)
Cosponsors
12 cosponsors

4 original · 8 later

4 R · 8 D

  1. Rep. Angie Craig (D-MN-2)· Original · Mar 17, 2023
  2. Rep. Glenn Grothman (R-WI-6)· Original · Mar 17, 2023
  3. Rep. Mark Pocan (D-WI-2)· Original · Mar 17, 2023
  4. Rep. Dina Titus (D-NV-1)· Original · Mar 17, 2023
  5. Rep. James Comer (R-KY-1)· Later · Mar 28, 2023
  6. Rep. Tony Cárdenas (D-CA-29)· Later · Apr 13, 2023
  7. Rep. David Scott (D-GA-13)· Later · Apr 25, 2023
  8. Rep. Andy Barr (R-KY-6)· Later · Apr 27, 2023
  9. Rep. Ann M. Kuster (D-NH-2)· Later · Jul 13, 2023
  10. Rep. Morgan McGarvey (D-KY-3)· Later · Jul 17, 2023
  11. Rep. Dan Crenshaw (R-TX-2)· Later · Jul 24, 2023
  12. Rep. Jason Crow (D-CO-6)· Later · Feb 15, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Mar 17, 2023 – Mar 24, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Mar 17, 2023
  2. HouseHealthReferred Mar 24, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. CBD Product Safety and Standardization Act of 2023

    Display title, Short title · Introduced in House

  2. To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes.

    Official title · Introduced in House